Consistent with SLC8A1 expression being a surrogate of LKB1 activity rather than LKB1 expression itself, we observed higher SLC8A1 levels in liver metastases than in skin metastases with no significant changes in LKB1 expression (Fig 4B). This evidence concerns the gene STK11 and neoplasm.